The anti-angiogenic agent thrombospondin-1 (TSP-1) inhibits growth of primary myeloma in vivo.

被引：0

作者：

Yata, K ^{[1
]}

Henderson, A ^{[1
]}

Yaccoby, S ^{[1
]}

机构：

[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA

来源：

BLOOD | 2003年 / 102卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

251

引用

页码：74A / 75A

页数：2

共 50 条

[31] Biophysical characterization, including disulfide bond assignments, of the anti-angiogenic type 1 domains of human thrombospondin-1 [J].

Huwiler, KG ;

Vestling, MM ;

Annis, DS ;

Mosher, DF .

BIOCHEMISTRY, 2002, 41 (48) :14329-14339

[32] Role of anti-angiogenic protein TSP-1 in MAGE-B2 driven cell proliferation [J].

Bagsby, Clarke ;

Colemon, Ashley ;

Ramanathan, Saumya .

FASEB JOURNAL, 2020, 34

[33] C-terminal thrombospondin-1 (TSP-1) peptide induces monocyte procoagulant activity. [J].

Brodde, MF ;

Jurk, K ;

Van Aken, H ;

Kehrel, BE .

BLOOD, 2001, 98 (11) :259A-259A

[34] DFMO upregulates transcription and translation of thrombospondin-1 (TSP-1) in vitro and increases steady state TSP-1 mRNA and protein levels in vivo in MDA-MB-435 breast cancer cells [J].

Manni, Andrea ;

Hu, Xin ;

Washington, Sharlene ;

Verderame, Michael F. ;

Rager, Terry .

CANCER RESEARCH, 2006, 66 (08)

[35] Metformin Induces Thrombospondin-1 in Metabolically Challenged Endothelial Cells: Implications in Anti-angiogenic Cancer Therapy [J].

Samuel, Samson Mathews ;

Ghosh, Suparna ;

Majeed, Yasser ;

Triggle, Chris R. .

FASEB JOURNAL, 2016, 30

[36] Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis [J].

Bruel, A ;

Touhami-Carrier, M ;

Thomaidis, A ;

Legrand, C .

ANTICANCER RESEARCH, 2005, 25 (2A) :757-764

[37] Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors [J].

van Eekelen, M. ;

Sasportas, L. S. ;

Kasmieh, R. ;

Yip, S. ;

Figueiredo, J-L ;

Louis, D. N. ;

Weissleder, R. ;

Shah, K. .

ONCOGENE, 2010, 29 (22) :3185-3195

[38] Preclinical anti-tumor efficacy of ABT-510 (thrombospondin-1 mimetic peptide), a novel anti-angiogenic agent, in hematological malignancies. [J].

Cikojevic, A ;

Wang, ES .

BLOOD, 2005, 106 (11) :681A-681A

[39] Anti-angiogenic therapy for bladder cancer: Synergy of 15PGJ2 and TSP-1 peptide mimetics [J].

Campbell, SC ;

Huang, HH ;

Volpert, O .

JOURNAL OF UROLOGY, 2002, 167 (04) :120-120

[40] The N-Terminal Domain of Thrombospondin-1: a Key for the Dual Effect of TSP-1 in Angiogenesis and Cancer Progression? [J].

Morandi, Veronica .

THESCIENTIFICWORLDJOURNAL, 2009, 9 :133-136

← 1 2 3 4 5 →